Literature DB >> 10839209

A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.

A A Spasov1, G K Wikman, V B Mandrikov, I A Mironova, V V Neumoin.   

Abstract

The objective was to investigate the stimulating and normalizing effect of the adaptogen Rhodiola rosea extract SHR-5 in foreign students during a stressful examination period. The study was performed as a double-blind, randomized and placebo-controlled with low repeated dose regime. The study drug and the placebo were taken for 20 days by the students during an examination period. The physical and mental performance were assessed before and after the period, based on objective as well as on subjective evaluation. The most significant improvement in the SHR-5 group was seen in physical fitness, mental fatigue and neuro-motoric tests (p <0.01). The self-assessment of the general well-being was also significantly (p < 0.05) better in the verum group. No significance was seen in the correction of text tests or a neuro-muscular tapping test. The overall conclusion is that the study drug gave significant results compared to the placebo group but that the dose level probably was suboptimal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839209     DOI: 10.1016/S0944-7113(00)80078-1

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  39 in total

1.  Dietary supplement with a combination of Rhodiola crenulata and Ginkgo biloba enhances the endurance performance in healthy volunteers.

Authors:  Zhang-jin Zhang; Yao Tong; Jun Zou; Pei-jie Chen; Ding-hai Yu
Journal:  Chin J Integr Med       Date:  2009-07-02       Impact factor: 1.978

2.  Salidroside stimulates DNA repair enzyme Parp-1 activity in mouse HSC maintenance.

Authors:  Xue Li; Jared Sipple; Qishen Pang; Wei Du
Journal:  Blood       Date:  2012-03-16       Impact factor: 22.113

3.  Hepatoprotective effect of Rhodiola imbricata rhizome against paracetamol-induced liver toxicity in rats.

Authors:  Ravichandran Senthilkumar; Rahul Chandran; Thangaraj Parimelazhagan
Journal:  Saudi J Biol Sci       Date:  2014-04-23       Impact factor: 4.219

4.  Non-Pharmacological Treatments for ADHD in Youth.

Authors:  Anup Sharma; Patricia L Gerbarg; Richard P Brown
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2015

5.  Evaluation of radioprotective activities Rhodiola imbricata Edgew--a high altitude plant.

Authors:  Rajesh Arora; Raman Chawla; Ravinder Sagar; Jagdish Prasad; Surendar Singh; Raj Kumar; Ashok Sharma; Shikha Singh; Rakesh Kumar Sharma
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

6.  Citrus aurantium and Rhodiola rosea in combination reduce visceral white adipose tissue and increase hypothalamic norepinephrine in a rat model of diet-induced obesity.

Authors:  Jessica L Verpeut; Amy L Walters; Nicholas T Bello
Journal:  Nutr Res       Date:  2013-05-08       Impact factor: 3.315

7.  Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window.

Authors:  Wenfang Lai; Zhenwei Zheng; Xiaoqin Zhang; Yicong Wei; Kedan Chu; John Brown; Guizhu Hong; Lidian Chen
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

8.  Binding to WGR domain by salidroside activates PARP1 and protects hematopoietic stem cells from oxidative stress.

Authors:  Xue Li; Ozlem Erden; Liang Li; Qidong Ye; Andrew Wilson; Wei Du
Journal:  Antioxid Redox Signal       Date:  2014-03-05       Impact factor: 8.401

9.  Salidroside exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signalling pathways.

Authors:  Yubo Tang; Corina Vater; Angela Jacobi; Cornelia Liebers; Xuenong Zou; Maik Stiehler
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

10.  Salidroside induces apoptosis in human ovarian cancer SKOV3 and A2780 cells through the p53 signaling pathway.

Authors:  Ge Yu; Na Li; Yan Zhao; Wei Wang; Xiao-Ling Feng
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.